Search for: "Doe v Johnson & Wales University"
Results 21 - 27
of 27
Sort by Relevance
|
Sort by Date
6 Nov 2013, 10:40 am
This time round, the offering consists of an article on one of this Kat's favourite topics, "‘Damages’ in European law and the traditional accounts of profit", written by Katfriend and scholar Phillip Johnson (Associate Professor of Intellectual Property, University College Dublin; Visiting Senior Fellow, Queen Mary University of London). [read post]
2 Sep 2013, 4:29 am
Panellists are Mr Justice Arnold, Chris Wadlow, Phillip Johnson and Birgit Clark. [read post]
10 Jun 2011, 10:21 am
Multi-talented London Mayor Boris Johnson has taught himself to read JIPLP by ear ... [read post]
26 May 2011, 6:00 am
Dr Strong, who is qualified as a lawyer at the New York and Illinois bars and as a solicitor of the Supreme Court of England and Wales, holds a Ph.D. in law from the University of Cambridge, a D.Phil. from the University of Oxford, a J.D. from Duke University, an M.P.W. from the University of Southern California and a B.A. from the University of Califo [read post]
10 May 2010, 2:59 am
As John Ikerd, Professor Emeritus of Agricultural Economics at the University of Missouri, Columbia, takes up the issue in a presentation entitled "Reweaving the Fabric of Rural America: Food as a Common Thread. [read post]
29 Jul 2008, 4:35 pm
This issue does too: there's an article, "Looking for zero-sum or win-win outcomes: a game-theoretical analysis of the fair dealing debate", by Yu-Lin Chang, whose excellent doctoral thesis submitted to Queen's University, Belfast, was examined last year by IPKat team blogger Jeremy. [read post]
7 Mar 2008, 2:00 am
: (IPBiz), US: Proposals for the approval of generic biologics under consideration: (Pharmacapsules@Gowlings), US: A paradigm shift in obviousness for pharma, biotech: (IP Law360), US: USPTO’s Bruce Kisliuk addresses ACI Pharma/biotech patent claim drafting and prosecution conference: (Patent Docs), US: New bill to provide biotech companies Sarbanes-Oxley relief: (California Biotech Law Blog), US: Biotech and pharma companies spent millions on lobbying in 2007: (Patent… [read post]
